Literature DB >> 11979344

Chronic dialysis patients have high risk for pulmonary embolism.

Daniel P Tveit1, Iman O Hypolite, Paul Hshieh, David Cruess, Lawrence Y Agodoa, Paul G Welch, Kevin C Abbott.   

Abstract

Pulmonary embolism has been considered uncommon in chronic dialysis patients, but has not been adequately studied in a large population. In the US Renal Data System (USRDS), 76,718 patients presenting with end-stage renal disease (ESRD) between January 1, 1996, and December 31, 1996, were analyzed in an historical cohort study. The outcome was hospitalizations with a primary discharge diagnosis of pulmonary embolism (International Classification of Diseases, Ninth Revision code 415.1x) occurring within 1 year of the first ESRD treatment and excluding those occurring after renal transplantation. For dialysis patients, hospitalization rates for pulmonary embolism were obtained from the hospitalization section of the 1999 USRDS. For the general population, hospitalization rates for pulmonary embolism were obtained from the National Hospital Discharge Survey for 1996. Comorbidities from the Medical Evidence Form (Centers for Medicare and Medicaid Services, previously known as the Health Care Financing Administration; form 2728) were used to generate approximated stratified models of adjusted incidence ratios for pulmonary embolism (comorbidities could not be stratified for the general population). In 1996, the overall incidence rate of pulmonary embolism was 149.90/100,000 dialysis patients compared with 24.62/100,000 persons in the US population, with an age-adjusted incidence ratio of 2.34 in dialysis patients. Younger dialysis patients had the greatest relative risk for pulmonary embolism. The age-adjusted incidence ratio of pulmonary embolism after excluding dialysis patients with known risk factors for pulmonary embolism was 2.11. Ninety-five percent confidence intervals for all age categories in both models were statistically significant. Chronic dialysis patients have high risk for pulmonary embolism, independent of comorbidity.

Entities:  

Mesh:

Year:  2002        PMID: 11979344     DOI: 10.1053/ajkd.2002.32774

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  37 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

Review 3.  Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms.

Authors:  Keattiyoat Wattanakit; Mary Cushman
Journal:  Curr Opin Pulm Med       Date:  2009-09       Impact factor: 3.155

Review 4.  Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride.

Authors:  Desmond Padhi; Robert Harris
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Pulmonary Hypertension in Hemodialysis Patients Following Repeated Endovascular Thrombectomy.

Authors:  Mu-Yang Hsieh; Lin Lin; Tsung-Yan Chen; Ren-Huei Wang; Su-Chin Huang; HsiuChiao Liu; Chao-Lun Lai; Shih-Yen Pu; Kuei-Chin Tsai; Chih-Cheng Wu
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

Review 6.  [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Authors:  G Schlieper; V Schwenger; A Remppis; T Keller; R Dechend; S Massberg; S Baldus; T Weinreich; G Hetzel; J Floege; F Mahfoud; D Fliser
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

7.  Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomy.

Authors:  Keisuke Yamasaki; Naoki Haruyama; Masatomo Taniguchi; Takahiro Nishida; Ryuji Tominaga; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  CEN Case Rep       Date:  2016-02-11

Review 8.  Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?

Authors:  Guido Finazzi; Giulio Mingardi
Journal:  Intern Emerg Med       Date:  2009-07-16       Impact factor: 3.397

9.  In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy.

Authors:  Fabio Fabbian; Massimo Gallerani; Marco Pala; Alfredo De Giorgi; Raffaella Salmi; Fabio Manfredini; Francesco Portaluppi; Francesco Dentali; Walter Ageno; Dimitri P Mikhailidis; Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2012-12-18       Impact factor: 3.397

Review 10.  Thrombosis in the uremic milieu--emerging role of "thrombolome".

Authors:  Moshe Shashar; Jean Francis; Vipul Chitalia
Journal:  Semin Dial       Date:  2014-06-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.